Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025

Core Insights - Edwards Lifesciences is set to announce its operating results for Q3 2025 on October 30, 2025, followed by a conference call to discuss these results [1][2]. Company Overview - Edwards Lifesciences is recognized as a leading global company in structural heart innovation, focusing on improving patient lives through advanced technologies and partnerships with healthcare stakeholders [3]. Financial Activities - The company has executed an accelerated share repurchase agreement to buy back $500 million of its common stock, bringing the total repurchased shares in 2025 to over $800 million [8]. Regulatory Developments - The U.S. Federal Trade Commission (FTC) has moved to block Edwards Lifesciences' proposed acquisition of JenaValve Technology, which the company believes will limit treatment options for patients with aortic regurgitation [9].